Form 4 for GILD Gilead Sciences
Accepted 2026-01-21 00:00:00 ET · period of report 2026-01-20 · accession 0001771814-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-01-21 | 2026-01-20 | GILD | Bluestone Jeffrey | Dir | M - OptEx | $67.45 | +5,000 | 13.9K | +56% | +$337.2K |
| D | 2026-01-21 | 2026-01-20 | GILD | Bluestone Jeffrey | Dir | S - Sale+OE | $123.50 | -5,000 | 8,920 | -36% | -$617.5K |
| D | 2026-01-21 | 2026-01-20 | GILD | Bluestone Jeffrey | Dir | M - OptEx | $0.00 | -5,000 | 4,665 | -52% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-20 | M | A | 5,000 | $67.45 | 13,920 | D | — | — | |
| 2 | Common | Common Stock | 2026-01-20 | S | D | 5,000 | $123.50 | 8,920 | D | — | — | |
| 3 | Derivative | Non-qualified Stock Option (Right to Buy) | 2026-01-20 | M | D | 5,000 | $0.00 | 4,665 | D | $67.45 · — to 2031-05-12 | 5,000 Common Stock | (F2) 25% of the shares subject to the option vest on each three-month anniversary from May 12, 2021 such that 100% of the shares subject to the option will be fully vested and exercisable upon the earlier of May 12, 2022 or the day immediately preceding the next regular annual stockholders meeting. |